Trade press release
March 12, 2025
With the kytero® 10, GEA introduces the world's smallest single use disk stack centrifuge. This mini centrifuge is particularly suitable for use in the biopharmaceutical, food and new food industries. (Photo: GEA)
Other models of the kytero® series cover ranges from 500 to 2,000 liters (batch).
Test users have found that this concept overcomes previous limitations. The results achieved can be scaled up to larger model variants and industrial production with classic stainless steel separators, which facilitates process transfer and validation.
The proven GEA disc stack centrifuge technology has been implemented in compact machines with easy-to-handle units that contain all parts that come into contact with the product. These units are exchanged after a production run, providing maximum safety against contamination. Gamma-treated exchangeable units are available as standard.
The new single use perfusion separators offer the same advantages as classic disk stack separators, but without the need for cleaning processes (CIP (cleaning-in-place) and SIP (sterilization-in-place). They are ready for the next process run in just a few minutes and require no media other than electricity and air. The compact design and the easy and self-explanatory operability enable simple operation in any system. The non-contact drive system breeze Drive® ensures safe operation under high biocontainment requirements.
The new kytero® 10 separators enable continuous operation over the perfusion period and continuous clarification of the fermentation broth. The clarified liquid, which usually contains the product, is continuously removed from the process and fed to the next process stages. Exceptions are bacterial processes and new food applications, where the cells are the valuable product. The concentrated biomass is gently returned to the bioreactor, ensuring high vitality and productivity.
GEA kytero® 10 - the world's smallest single use disk stack centrifuge (Photo: GEA)
Continuous processing reduces the size of the bioreactor and significantly lowers costs. Operators no longer have to wait for the end of a batch run to separate cells and recover the target protein. Instead of discarding or harvesting cells at the end, they are returned to the bioreactor and only discharged partially so that production can run continuously for weeks. This makes it possible to bring new products to market faster and more cost-effectively.
GEA developed the kytero® 10 separators to provide the biopharmaceutical industry with robust and scalable upstream processes. The demand for vaccines and monoclonal antibodies (mAbs) is continuously increasing. These separators are designed for high-intensity, continuous cell separation and round off the kytero® series at the bottom. Monoclonal antibodies are successfully used for the treatment of cancer and other serious diseases.
The kytero® 10 will be introduced in the new GEA machine design, which emphasizes a clear recognition effect and the affiliation to the GEA product portfolio.
GEA は、世界レベルの食品製造プロセス技術を有するとともに、乳業、飲料、パーソナル・ホームケア、化学など食品以外の幅広い分野にも実績があり、2019年度の連結売上高は約49億ユーロとなりました。